TFThomas Armin Fuchsluger

Thomas Armin Fuchsluger

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thomas Armin Fuchsluger has a total of 87 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Infectious Keratitis: A Retrospective Analysis of a Tertiary Care Center

    by Jana Schaetzel, Taos Batal, Marcus Walckling, Thomas A. Fuchsluger

    Background/Objectives: Infectious keratitis is a vision-threatening disease. Its prevalence and specific pathogens vary by geographic location. This study characterizes risk profiles, clinical manifestations, and treatment outcomes for various pathogens in the Rostock area. Results: The study included 65 patients (38 viral, 14 bacterial, seven fungal, six parasitic) with a minimum follow-up of three months. The cohort had a mean age of 59 ± 19 years, with 49% female and 51% male participants. All groups showed significant improvement in visual acuity (viral −0.3 logMAR, p = 0.011; parasitic −0.8 logMAR, p = 0.043; fungal −0.9 logMAR, p = 0.018; Wilcoxon). Only the bacterial group did not reach statistical significance (−0.3 logMAR, p = 0.169; Wilcoxon). Final visual acuity did not differ significantly between medical and surgical treatments. Conclusions: No treatment modality (medical vs. surgical) showed superiority regarding visual outcome across pathogen groups. Early diagnosis and prompt therapy initiation are essential to improve visual prognosis and reduce complications.

  • Open Access

    Multimodal Imaging of the Corneal Endothelial Transition Zone Reveals Progenitor Cell Population

    by Sonika Rathi, Patricia Hülse, Susanne Staehlke, Marcus Walckling, Mahmoud Anwar, Peter Trosan, Sebastian Bohn, Oliver Stachs, Gary S. L. Peh, Gary Hin-Fai Yam, et al.

    The assessment of donor corneas is currently based solely on central endothelial cell (EC) density, which potentially overlooks the transition zone (TZ) regenerative potential. Therefore, the present study characterizes TZ using multimodal imaging techniques to understand its regenerative potential and refine the assessment of donor tissue. Ex vivo donor corneas (n = 41) were examined using phase-contrast microscopy for EC counting and reflectance confocal microscopy (HRTII/RCM) for non-invasive visualization of the TZ. A subset of eight of these corneas underwent ultrastructural analysis using field-emission scanning electron microscopy (SEM) and immunostaining analysis using confocal microscopy. We observed a significant decrease in central EC density (p < 0.001) with increasing storage duration and donor age, while TZ width and TZ surface cell count remained stable. HRTII/RCM and SEM revealed distinct morphological differences (small, polygonal cells, irregular arrangement) in the TZ compared to the peripheral endothelium (PE). Immunostaining revealed elevated expression of progenitor markers (Nestin, ABCG2, SOX2, Lgr5, Vimentin) and reduced expression of endothelial markers (ZO1 and Na/K-ATPase) in the TZ compared to the PE, indicating the presence of a stem cell-like population. These findings suggest that TZ may contribute to endothelial cell regeneration, and HRTII/RCM could serve as a novel tool for TZ evaluation in low EC count donor corneas.


  • Chemical Burns

    by Thomas A. Fuchsluger

  • Open Access

    Suppressing Pro-Apoptotic Proteins by siRNA in Corneal Endothelial Cells Protects against Cell Death

    by Susanne Staehlke, Siddharth Mahajan, Daniel Thieme, Peter Trosan, Thomas A. Fuchsluger

    Corneal endothelial cells (CE) are critical for the cornea’s transparency. For severe corneal damage, corneal tissue transplantation is the most promising option for restoring vision. However, CE apoptotic cell death occurs during the storage of donor corneas for transplantation. This study used small interfering (si)RNA-mediated silencing of pro-apoptotic proteins as a novel strategy to protect CE against apoptosis. Therefore, the pro-apoptotic proteins Bax and Bak were silenced in the human corneal endothelial cell line (HCEC-12) by transfection with Accell™siRNA without any adverse effects on cell viability. When apoptosis was induced, e.g., etoposide, the caspase-3 activity and Annexin V-FITC/PI assay indicated a significantly reduced apoptosis rate in Bax+Bak-siRNA transfected HCECs compared to control (w/o siRNA). TUNEL assay in HCECs exposed also significantly lower cell death in Bax+Bak-siRNA (7.5%) compared to control (w/o siRNA: 32.8%). In ex vivo donor corneas, a significant reduction of TUNEL-positive CEs in Bax+Bak-siRNA corneas (8.1%) was detectable compared to control-treated corneas (w/o siRNA: 27.9%). In this study, we demonstrated that suppressing pro-apoptotic siRNA leads to inhibiting CE apoptosis. Gene therapy with siRNA may open a new translational approach for corneal tissue treatment in the eye bank before transplantation, leading to graft protection and prolonged graft survival.


  • Open Access

    The Biocompatibility Analysis of Artificial Mucin-Like Glycopolymers

    by P. Trosan, J. S. J. Tang, R. R. Rosencrantz, L. Daehne, A. Debrassi Smaczniak, S. Staehlke, S. Chea, T. A. Fuchsluger

    The ocular surface is covered by a tear film consisting of an aqueous/mucin phase and a superficial lipid layer. Mucins, highly O-glycosylated proteins, are responsible for lubrication and ocular surface protection. Due to contact lens wear or eye disorders, lubrication of the ocular surface can be affected. Artificial glycopolymers which mimic natural mucins could be efficient in ophthalmic therapy. Various neutral, positively, and negatively charged mucin-mimicking glycopolymers were synthesized (n = 11), cultured in different concentrations (1%, 0.1%, and 0.01% w/v) with human corneal epithelial cells (HCE), and analyzed by various cytotoxicity/viability, morphology, and immunohistochemistry (IHC) assays. Six of the eleven glycopolymers were selected for further analysis after cytotoxicity/viability assays. We showed that the six selected glycopolymers had no cytotoxic effect on HCE cells in the 0.01% w/v concentration. They did not negatively affect cell viability and displayed both morphology and characteristic markers as untreated control cells. These polymers could be used in the future as mucin-mimicking semi-synthetic materials for lubrication and protection of the ocular surface.


  • Participation in a clinical trial—Is that something for me?

    by Katrin Lorenz, Daniel Böhringer, Barbara Wilhelm, Sabine Aisenbrey, Katharina Allgeier, Isabella Baur, Eckart Bertelmann, Christian Karl Brinkmann, Lars Choritz, Christoph Deuter, et al.

    Zusammenfassung Fragestellung Die Zulassung neuer Therapien in der Augenheilkunde macht klinische Studien essenziell notwendig. Regelmäßig stellt die Rekrutierung geeigneter Studienpatienten eine große Herausforderung für die teilnehmenden Kliniken dar. Viele Patienten haben grundsätzliche Vorbehalte und Ängste gegenüber Studien, die sie von einer Teilnahme abhalten. Da diese Bedenken an allen Standorten im Land ähnlich sind, soll ihnen mit einem breit anwendbaren Video begegnet werden. Erstmalig werden darin die Aspekte einer Studienteilnahme rein aus der Patientenperspektive vermittelt. Methodik Das Konzept für das Video wurde von der AG DOG (Deutsche Ophthalmologische Gesellschaft) Klinische Studienzentren erarbeitet. An mehreren Standorten wurden Patienten für die Mitwirkung gesucht und 2 geeignete Protagonisten ausgewählt. Die Mitwirkung war freiwillig und ehrenamtlich. Die Dreharbeiten fanden in Q (Quartal) 3 und Q4 2021 in Baden-Württemberg statt. Die Produktion lag in den Händen der Agentur grasshopper kreativ, Tübingen. Ergebnis Die beiden Patienten schildern ihre eigenen Bedenken vor der Studie und wie sie die Studienteilnahme selbst erlebt haben. Dabei kommen Aspekte wie die Freiwilligkeit, das Rücktrittsrecht, Angst vor unangenehmen Untersuchungen, die zeitliche Belastung u. a. m. zur Sprache. Die Patienten gehen auch auf ihre persönliche Motivation zur Teilnahme ein. Das Video ist authentisch in seiner Wirkung, in deutscher Sprache gehalten und mit Untertiteln für Bereiche versehen, wo es ohne Ton präsentiert werden muss. Diese Untertitel sind auch in englischer Sprache verfügbar, um den Interessentenkreis auszuweiten. Schlussfolgerung Mit dem Video steht ein wichtiges Instrument zur Aufklärung von Patienten und für die Rekrutierung klinischer Studien an Augenkliniken kostenfrei zur Verfügung.


  • Open Access

    Schwann Cells Promote Myogenic Differentiation of Myoblasts and Adipogenic Mesenchymal Stromal Cells on Poly-ɛ-Caprolactone-Collagen I-Nanofibers

    by Aijia Cai, Zeng-Ming Zheng, Marcus Himmler, Dirk W. Schubert, Thomas A. Fuchsluger, Volker Weisbach, Raymund E. Horch, Andreas Arkudas

    For the purpose of skeletal muscle tissue engineering, different cell types have been investigated regarding their myogenic differentiation potential, including co-cultured myoblasts and adipogenic mesenchymal stromal cells (Mb/ADSC). As neural cells enhance synaptic junction formation, the aim of this study was to co-culture Schwann cells (SCs) with Mb/ADSC on biocompatible electrospun aligned poly-ε-polycaprolacton (PCL)-collagen I-nanofibers. It was hypothesized that SCs, as part of the peripheral nervous system, promote the myogenic differentiation of Mb/ADSC co-cultures. Mb/ADSC were compared to Mb/ADSC/SC regarding their capacity for myogenic differentiation via immunofluorescent staining and gene expression of myogenic markers. Mb/ADSC/SC showed more myotubes after 28 days of differentiation (p ≤ 0.05). After 28 days of differentiation on electrospun aligned PCL-collagen I-nanofibers, gene expression of myosin heavy chains (MYH2) and myogenin (MYOG) was upregulated in Mb/ADSC/SC compared to Mb/ADSC (p ≤ 0.01 and p ≤ 0.05, respectively). Immunofluorescent staining for MHC showed highly aligned multinucleated cells as possible myotube formation in Mb/ADSC/SC. In conclusion, SCs promote myogenic differentiation of Mb/ADSC. The co-culture of primary Mb/ADSC/SC on PCL-collagen I-nanofibers serves as a physiological model for skeletal muscle tissue engineering, applicable to future clinical applications.


  • Open Access

    Electrospun PCL Scaffolds as Drug Carrier for Corneal Wound Dressing Using Layer-by-Layer Coating of Hyaluronic Acid and Heparin

    by Marcus Himmler, Dirk W. Schubert, Lars Dähne, Gabriella Egri, Thomas A. Fuchsluger

    Due to its ability to reduce scarring and inflammation, human amniotic membrane is a widely used graft for wound dressings after corneal surgery. To overcome donor dependency and biological variances in the donor tissue, artificial nanofibrous grafts acting as drug carrier systems are promising substitutes. Electrospun nanofibrous scaffolds seem to be an appropriate approach as they offer the properties of permeable scaffolds with a high specific surface, the latter one depending on the fiber diameter. Electrospun scaffolds with fiber diameter of 35 nm, 113 nm, 167 nm and 549 nm were manufactured and coated by the layer-by-layer (LbL) technology with either hyaluronic acid or heparin for enhanced regeneration of corneal tissue after surgery. Studies on drug loading capacity and release kinetics defined a lower limit for nanofibrous scaffolds for effective drug loading. Additionally, scaffold characteristics and resulting mechanical properties from the application-oriented characterization of suture pullout from suture retention tests were examined. Finally, scaffolds consisting of nanofibers with a mean fiber diameter of 113 nm were identified as the best-performing scaffolds, concerning drug loading efficiency and resistance against suture pullout.